Examining the Effectiveness of Dynamic Visual Noise (DVN) for Reducing Alcohol Cravings and Consumption in College Students
- Conditions
- CravingAlcohol Drinking
- Registration Number
- NCT07157124
- Lead Sponsor
- University of Wyoming
- Brief Summary
The goal of this clinical trial is to examine whether dynamic visual noise (DVN), a short video array of rapidly moving black and white squares, reduces cravings for and consumption of alcohol in college students who drink alcohol and experience cravings for alcohol at least once a week on average. A second goal of this clinical trial is to examine whether changes in attentional bias towards alcohol (that is, the tendency to pay greater mental and visual attention towards alcohol over other things in one's environment) is a mechanism by which DVN reduces alcohol cravings and consumption.
Researchers will compare DVN to static visual noise (SVN), which is a still image of black and white squares that has been used as a control condition for DVN in prior literature.
Participants will:
1. Visit the laboratory once to complete the baseline data collection
2. Watch the DVN or SVN every day for seven days (including the day of the laboratory visit)
3. Complete daily follow-ups for six days following the day of the laboratory visit
4. Complete a final follow-up on the seventh day following the laboratory visit
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 62
- Must report being between the age of 18 and 29
- Must report drinking alcohol at least once per week on average over the past month
- Must report having drank beer or alcoholic seltzers in the past month
- Must endorse experiencing craving at least once per week over the past month, on average
- Must report not currently receiving nor planning to seek any other treatment for their alcohol use within the next 30 days
- Must report owning a personal electronic device with access to the Internet
- Must report owning or having access to a computer with access to the Internet
- Major visual impairment (i.e., legal blindness or color blindness)
- History of seizures and/or diagnosed seizure disorder
- Current medical diagnosis provided by a qualified professional (i.e., psychologist, psychiatrist, neurologist) that is characterized by cognitive impairment (i.e., neurocognitive disorder due to traumatic brain injury, traumatic brain injury, HIV infection, post-concussive syndrome, and intellectual disability)
- Concussion in the past month
- A current diagnosis of any substance use disorder besides alcohol use disorder, as determined by a qualified professional (i.e., psychologist, psychiatrist)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Strength of Alcohol Craving Baseline and 1-week follow-up Strength of alcohol craving will be measured using the Craving Experiences Questionnaire - Strength (CEQ-S). The measure inquires about the individual's past-week craving experiences. Higher average scores indicate stronger past-week cravings. Changes in mean craving will be calculated as changes in mean strength of past-week alcohol craving at follow-up relative to baseline for each condition.
Frequency of Craving Baseline and 1-week follow-up Frequency of alcohol craving will be measured using the Craving Experiences Questionnaire - Frequency (CEQ-F). The measure inquires about the individual's past-week craving experiences. Higher average scores indicate more frequent past-week craving. Changes will be calculated as changes in mean frequency of past-week alcohol craving at follow-up relative to baseline for each condition.
Alcohol Consumption Baseline and 1-week follow-up At baseline and follow-up, participants will complete the Daily Drinking Questionnaire (DDQ) to indicate the extent of their past-week alcohol consumption. Higher total scores indicate more past-week alcohol consumption. Changes will be calculated as changes in mean past-week alcohol use at follow-up relative to baseline for each condition.
Attentional Bias towards Alcohol Baseline and 1-week follow-up Attentional bias will be measured at the initial laboratory session and at the 1-week final follow-up via the Alcohol Visual Probe task. Changes will be examined as mean changes in reaction time at follow-up minus reaction time at baseline for each condition.
- Secondary Outcome Measures
Name Time Method Immediate Changes in Strength of Alcohol Craving Before and After DVN/SVN Task Baseline Participants will view their assigned intervention (i.e., DVN or SVN) as part of the initial baseline visit. Participants will first undergo a craving induction paradigm. Participants will then complete the CEQ-Strength-Now (CEQ-S-N) to indicate the strength of their current craving. Then, participants will view the DVN or SVN (depending on their assigned condition). After viewing the task, participants will complete the CEQ-S-N again. Higher average scores on the CEQ-S-N indicate stronger current moment cravings. Immediate changes in craving will be calculated as the average CEQ-S-N score before viewing the task minus average CEQ-S-N score after viewing the task. A mean change score will be calculated for each condition.
Immediate Changes in Strength of Craving Before and After DVN/SVN 1-Week Intervention Period, Between Baseline Visit and 1-week Follow-Up During the intervention phase, participants will be able to freely access their assigned intervention whenever they experience a craving. When they access the intervention, participants will first be asked to indicate, using a 0-100 Visual Analogue Scale (VAS), the strength of their current cravings for alcohol (i.e., "How strong is your craving for alcohol RIGHT NOW?"). They will then view their assigned intervention for at least 30 seconds. Immediately after viewing their intervention, they will complete the same VAS item. The change score will be calculated as the craving score before viewing minus the craving score after each viewing. A mean change score will be calculated for each condition.
Trial Locations
- Locations (1)
University of Wyoming
🇺🇸Laramie, Wyoming, United States
University of Wyoming🇺🇸Laramie, Wyoming, United StatesEmma L Winterlind, MPSPrincipal InvestigatorAlison Looby, PhDContactalooby@uwyo.eduAlison Looby, Ph.DPrincipal Investigator